Navigation Links
NeuMedics Invited to Speak at the Life Science Innovation Northwest 2016 in Seattle

NeuMedics Inc. is pleased to announce that CEO Iain Duncan has been invited to give a podium presentation at Life Science Innovation Northwest on June 2, 2016. The session begins at 1:10 PM and Iain will present the proof of concept data that demonstrates NeuMedics compound and propriety microemulsion can be successfully used as a topical agent and a treatment for ophthalmic complications of diabetes.

Mr. Duncan will also detail the results of a proof of principle study that was made possible through a grant from Washington State Life Science Discovery Fund.

“NM108 has a different mechanism of action than all of the anti-VEGF drugs on the market and currently in development,” says Duncan, “It targets the micro glia and short circuits the inflammation inside the eye that leads to the formation of VEGF. Our goal is to eliminate the need for intravitreal injection, the current standard of care for people who suffer from diabetic retinopathies.”

According to the U.S. Centers for Disease Control and Prevention, Diabetic Retinopathy is the leading cause of blindness in diabetics worldwide and The World Health Organization estimates 11% of the 347 million people suffering from diabetes also suffer from Diabetic Retinopathy. Intraocular injection of vascular endothelial growth factor (VEGF) inhibitors dominates the available therapies for the treatment of Diabetic Retinopathy, Diabetic Macular Edema, and Retinal Vein Occlusion. There is a significant need for effective and patient-friendly therapeutics for retinal diseases that address new cellular pathways, which can be regularly administered as an eye drop.

Event Information:

Life Science Innovation Northwest
When: June 1-2, 2016
Where: Washington State Convention Center
800 Convention Place
Seattle, WA.

About NeuMedics
NeuMedics is a specialty biopharmaceutical company based in Seattle that is focused on improving patients' lives by identifying and developing, novel therapeutics for the treatment of retinal diseases that can be safely and chronically administered as an eye drop.

For more information, please go to

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. NeuMedics Inc. Selected to Present at Cavendish Global Health Impact Forum
2. Kinetiq to attend DIA China in Beijing, Quorum Review IRB invited to speak at Peking University
3. DunhamTrimmer LLC Invited Speaker on Biological Agriculture Markets at Jefferies Conference
4. Health & Technology Leaders Invited to Participate in Co-Design of Health Care Delivery
5. DunhamTrimmer LLC Invited Speaker on Biocontrol at Jefferies Conference
6. Whitehouse Laboratories Invited to Participate in INTERPHEX Live Program
7. Adaptive Biotechnologies Invited to Present at Upcoming Conferences
8. Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland
9. Dr. Ira Williams Invited To IHI 25th National Forum On Quality Improvement In Health Care
10. Garnero invited by Netanyahu to be a speaker at major Israel Biofuel Conference
11. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference
Post Your Comments:
(Date:5/4/2019)... ... May 03, 2019 , ... More than ... Dakila Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, last Thursday ... detailed the results of some research carried out by the association, in partnership ...
(Date:5/2/2019)... Md. (PRWEB) , ... April ... ... to the International Organization for Standardization ISO 9001:2015 standard, REPROCELL USA Inc. ... meet customer requirements. In addition, REPROCELL USA Inc. aims to enhance customer ...
(Date:5/2/2019)... (PRWEB) , ... May 02, 2019 , ... Stay on ... biotech, medical device and food industries. Access to all webinars is free, so be ... relevant in your field! , Visit to see our upcoming webinars: ...
(Date:5/2/2019)... ... May 02, 2019 , ... Boston ... greater Boston area. Gone are the days of painful hair transplant procedures. Boston ... Restoration System is the only robotic intelligent solution to offer a minimally invasive ...
Breaking Biology Technology:
(Date:6/4/2019)... , ... June 04, 2019 , ... ... announced the appointment of Susan Murphy as the new President of Molecular Devices, ... by Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in ...
(Date:6/1/2019)... ... May 31, 2019 , ... The University ... recently invested in BioFactura’s $6M Series B Financing Round. , “With the ... investors who bring significant financial and business resources to bear as we advance ...
(Date:5/31/2019)... ... 31, 2019 , ... The OilComm Conference & Exposition, held ... that Ben Reiter, Senior Writer at Sports Illustrated and Author of Astroball, will ... predicted the Houston Astros would win the MLB championship in 2014 when they ...
Breaking Biology News(10 mins):